Biology of Disease studies disease mechanisms via internships in pre-clinical and clinical research in medical, biomedical, biological, industrial and veterinary labs.
The programme starts with Introducing Life Sciences, a mandatory introduction week for all Master’s students of the GSLS.
Two tracks are offered:
Cardiovascular research: within the theme Heart Failure, research focuses on biomolecular, electrophysiological and clinical aspects of cardiac arrhythmia, stem cells (cardiac progenitor stem cells), chronic heart failure, cardiac hypertrophy and issues of heart transplantation, cardiac surgery and MRI. Within the theme Atherothrombosis, research is aiming to enhance knowledge concerning vascular remodeling, plaque vulnerability, relevance of toll-like receptors, coagulation, arteriogenesis, thrombogenicity of platelets and protein misfolding.
Biology of Disease: offers the opportunity to focus on more than one clinical specialization, enabling students to conduct research projects on different subjects and diseases in various pre-clinical and clinical labs.
The central theme of the Master’s programme in Biology of Disease is the translation of a clinical problem (disease) into a scientifically secure experiment or model in order to study the underlying mechanism of the disease. Such experiments and models can reveal therapeutic leads. Research questions may relate to all organizational levels of the body.
On completing the programme, you will be able to use various advanced research techniques. The MSc in Biology of Disease is particularly suited to performing disease-related research in co-operation with clinical and pre-clinical staff.
Our programme is directly linked to the PhD programme Cardiovascular Research of the Graduate School of Life Sciences.
For more information on the Biology of Disease Master’s programme, visit our website.
*Since 2018-2019, Introducing Life Sciences, together with the Life Sciences Seminars and Navigation Towards Personal Excellence, is part of the course Life Sciences Academy.